Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracaine for Pain Management in Acute Corneal Abrasion
NCT02483897Phase 3Withdrawn
- Sponsor
- Queen's University
- Start
- Jun 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tetracaine in corneal abrasion, sponsored by Queen's University. Planned start Jun 2015; status: withdrawn.
02
Drugs
tetracaine
03
Conditions
corneal abrasion
Beyond the preview
Go deeper on NCT02483897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483897.